Document
type: Class

Continuant
type: Class

Entity
type: Class

Future Medicinal Chemistry
type: Document
type: Periodical
publication venue for: Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: Experimental evidence and therapeutic implications
type: Thing
type: Generically Dependent Continuant
type: Journal
type: Entity
type: Information Content Entity
type: Collection
type: Continuant

Generically Dependent Continuant
type: Class

RDF description of Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: Experimental evidence and therapeutic implications - http://orbis.uaslp.mx/vivo/individual/scopus3187
rights: termsOfUse
date: 2026-08-27T05:31:13
publisher: vivo
type: Document

Article
type: Class

Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: Experimental evidence and therapeutic implications
estado: published
volume: 4
chemicalscas: mitogen activated protein kinase, 142243-02-5; somatomedin C, 67763-96-6; Interleukin-6
pmid: 23190106
doi: 10.4155/fmc.12.156
e iscopus: 2-s2.0-84870410831
page end: 2192
related by: authorship_18531
type: Document
abstract: Many neuropsychiatric conditions are primed or triggered by different types of stressors. The mechanisms through which stress induces neuropsychiatric disease are complex and incompletely understood. A 'double hit hypothesis of neuropsychiatric disease postulates that stress induces maladaptive behavior in two phases separated by a dormant period. Recent research shows that the pleiotropic cytokine IL-6 is released centrally and peripherally following physical and psychological stress. In this article, we analyze evidence from clinics and animal models suggesting that stress-induced elevation in the levels of IL-6 may play a key role in the etiology of a heterogeneous family of hyperexcitable central conditions including epilepsy, schizophrenic psychoses, anxiety and disorders of the autistic spectrum. The cellular mechanism leading to hyperexcitable conditions might be a decrease in inhibitory/excitatory synaptic balance in either or both temporal phases of the conditions. Following these observations, we discuss how they may have important implications for optimal prophylactic and therapeutic pharmacological treatment. © 2012 Future Science Ltd.
page start: 2177
related by: authorship_18532
type: Continuant
type: Generically Dependent Continuant
related by: authorship_18533
freetext keyword: interleukin 6; mitogen activated protein kinase; somatomedin C; STAT protein; anxiety disorder; article; autism; central nervous system; cytokine release; epilepsy; GABAergic system; priority journal; schizophrenia; schizophreniform disorder; signal transduction; stress; synapse; Animals; Anxiety Disorders; Brain; Child; Child Development Disorders, Pervasive; Drug Discovery; Epilepsy; Humans; Interleukin-6; Molecular Targeted Therapy; Schizophrenia; Stress, Physiological; Stress, Psychological
type: Article
date time value: article date 3188
has publication venue: Future Medicinal Chemistry
crisid: 3188
type: Information Content Entity
most specific type: Document
type: Entity
most specific type: Article
origen: scopus
type: Thing
issue: 17

Information Content Entity
type: Class